ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paediatric Influenza Prevention Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-21M18486
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Paediatric Influenza Prevention Market Research Report 2024
BUY CHAPTERS

Global Paediatric Influenza Prevention Market Research Report 2024

Code: QYRE-Auto-21M18486
Report
November 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Viatris
Hulan Bio
Astrazeneca plc
CCBIO
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Paediatric Influenza Prevention Market Size

The global Paediatric Influenza Prevention market was valued at US$ 1662 million in 2023 and is anticipated to reach US$ 2164 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

Paediatric Influenza Prevention Market

Paediatric Influenza Prevention Market

Pediatric influenza prevention focuses on strategies to protect children from the flu. This includes annual flu vaccination, which is highly recommended for children over six months old, as well as practices like regular handwashing, covering coughs, and avoiding close contact with infected individuals. Because young children are more vulnerable to severe flu complications, preventive measures are essential in minimizing their risk of infection and helping to prevent flu spread within families and communities.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Paediatric Influenza Prevention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paediatric Influenza Prevention.
The Paediatric Influenza Prevention market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Paediatric Influenza Prevention market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paediatric Influenza Prevention manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Paediatric Influenza Prevention Market Report

Report Metric Details
Report Name Paediatric Influenza Prevention Market
Accounted market size in 2023 US$ 1662 million
Forecasted market size in 2030 US$ 2164 million
CAGR 3.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Public
  • Private
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, CSL, GSK, Viatris, Hulan Bio, AstraZeneca, CCBIO, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Paediatric Influenza Prevention manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Paediatric Influenza Prevention in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Paediatric Influenza Prevention Market growing?

Ans: The Paediatric Influenza Prevention Market witnessing a CAGR of 3.9% during the forecast period 2024-2030.

What is the Paediatric Influenza Prevention Market size in 2030?

Ans: The Paediatric Influenza Prevention Market size in 2030 will be US$ 2164 million.

Who are the main players in the Paediatric Influenza Prevention Market report?

Ans: The main players in the Paediatric Influenza Prevention Market are Sanofi, CSL, GSK, Viatris, Hulan Bio, AstraZeneca, CCBIO, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Paediatric Influenza Prevention Market report?

Ans: The Applications covered in the Paediatric Influenza Prevention Market report are Public, Private

What are the Type segmentation covered in the Paediatric Influenza Prevention Market report?

Ans: The Types covered in the Paediatric Influenza Prevention Market report are Nasal Spray, Injection

Recommended Reports

Pediatric Vaccines

Pediatric Respiratory

Child Healthcare

1 Paediatric Influenza Prevention Market Overview
1.1 Product Definition
1.2 Paediatric Influenza Prevention by Type
1.2.1 Global Paediatric Influenza Prevention Market Value Comparison by Type (2024-2030)
1.2.2 Nasal Spray
1.2.3 Injection
1.3 Paediatric Influenza Prevention by Application
1.3.1 Global Paediatric Influenza Prevention Market Value by Application (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Paediatric Influenza Prevention Market Size Estimates and Forecasts
1.4.1 Global Paediatric Influenza Prevention Revenue 2019-2030
1.4.2 Global Paediatric Influenza Prevention Sales 2019-2030
1.4.3 Global Paediatric Influenza Prevention Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paediatric Influenza Prevention Market Competition by Manufacturers
2.1 Global Paediatric Influenza Prevention Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paediatric Influenza Prevention Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paediatric Influenza Prevention Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Paediatric Influenza Prevention, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paediatric Influenza Prevention, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paediatric Influenza Prevention, Product Type & Application
2.7 Global Key Manufacturers of Paediatric Influenza Prevention, Date of Enter into This Industry
2.8 Global Paediatric Influenza Prevention Market Competitive Situation and Trends
2.8.1 Global Paediatric Influenza Prevention Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Paediatric Influenza Prevention Players Market Share by Revenue
2.8.3 Global Paediatric Influenza Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Paediatric Influenza Prevention Market Scenario by Region
3.1 Global Paediatric Influenza Prevention Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paediatric Influenza Prevention Sales by Region: 2019-2030
3.2.1 Global Paediatric Influenza Prevention Sales by Region: 2019-2024
3.2.2 Global Paediatric Influenza Prevention Sales by Region: 2025-2030
3.3 Global Paediatric Influenza Prevention Revenue by Region: 2019-2030
3.3.1 Global Paediatric Influenza Prevention Revenue by Region: 2019-2024
3.3.2 Global Paediatric Influenza Prevention Revenue by Region: 2025-2030
3.4 North America Paediatric Influenza Prevention Market Facts & Figures by Country
3.4.1 North America Paediatric Influenza Prevention Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paediatric Influenza Prevention Sales by Country (2019-2030)
3.4.3 North America Paediatric Influenza Prevention Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paediatric Influenza Prevention Market Facts & Figures by Country
3.5.1 Europe Paediatric Influenza Prevention Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paediatric Influenza Prevention Sales by Country (2019-2030)
3.5.3 Europe Paediatric Influenza Prevention Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paediatric Influenza Prevention Market Facts & Figures by Region
3.6.1 Asia Pacific Paediatric Influenza Prevention Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paediatric Influenza Prevention Sales by Region (2019-2030)
3.6.3 Asia Pacific Paediatric Influenza Prevention Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Paediatric Influenza Prevention Market Facts & Figures by Country
3.7.1 Latin America Paediatric Influenza Prevention Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paediatric Influenza Prevention Sales by Country (2019-2030)
3.7.3 Latin America Paediatric Influenza Prevention Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paediatric Influenza Prevention Market Facts & Figures by Country
3.8.1 Middle East and Africa Paediatric Influenza Prevention Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paediatric Influenza Prevention Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paediatric Influenza Prevention Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paediatric Influenza Prevention Sales by Type (2019-2030)
4.1.1 Global Paediatric Influenza Prevention Sales by Type (2019-2024)
4.1.2 Global Paediatric Influenza Prevention Sales by Type (2025-2030)
4.1.3 Global Paediatric Influenza Prevention Sales Market Share by Type (2019-2030)
4.2 Global Paediatric Influenza Prevention Revenue by Type (2019-2030)
4.2.1 Global Paediatric Influenza Prevention Revenue by Type (2019-2024)
4.2.2 Global Paediatric Influenza Prevention Revenue by Type (2025-2030)
4.2.3 Global Paediatric Influenza Prevention Revenue Market Share by Type (2019-2030)
4.3 Global Paediatric Influenza Prevention Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paediatric Influenza Prevention Sales by Application (2019-2030)
5.1.1 Global Paediatric Influenza Prevention Sales by Application (2019-2024)
5.1.2 Global Paediatric Influenza Prevention Sales by Application (2025-2030)
5.1.3 Global Paediatric Influenza Prevention Sales Market Share by Application (2019-2030)
5.2 Global Paediatric Influenza Prevention Revenue by Application (2019-2030)
5.2.1 Global Paediatric Influenza Prevention Revenue by Application (2019-2024)
5.2.2 Global Paediatric Influenza Prevention Revenue by Application (2025-2030)
5.2.3 Global Paediatric Influenza Prevention Revenue Market Share by Application (2019-2030)
5.3 Global Paediatric Influenza Prevention Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Paediatric Influenza Prevention Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Paediatric Influenza Prevention Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Paediatric Influenza Prevention Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Paediatric Influenza Prevention Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Company Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hulan Bio Paediatric Influenza Prevention Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Paediatric Influenza Prevention Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.7.1 CCBIO Company Information
6.7.2 CCBIO Description and Business Overview
6.7.3 CCBIO Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CCBIO Paediatric Influenza Prevention Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinovac Paediatric Influenza Prevention Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BCHT Paediatric Influenza Prevention Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu GDK Paediatric Influenza Prevention Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Paediatric Influenza Prevention Sales, Revenue and Gross Margin (2019-2024)
6.11.4 KM Biologics Paediatric Influenza Prevention Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paediatric Influenza Prevention Industry Chain Analysis
7.2 Paediatric Influenza Prevention Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paediatric Influenza Prevention Production Mode & Process
7.4 Paediatric Influenza Prevention Sales and Marketing
7.4.1 Paediatric Influenza Prevention Sales Channels
7.4.2 Paediatric Influenza Prevention Distributors
7.5 Paediatric Influenza Prevention Customers
8 Paediatric Influenza Prevention Market Dynamics
8.1 Paediatric Influenza Prevention Industry Trends
8.2 Paediatric Influenza Prevention Market Drivers
8.3 Paediatric Influenza Prevention Market Challenges
8.4 Paediatric Influenza Prevention Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Viatris
Hulan Bio
Astrazeneca plc
CCBIO
Sinovac
BCHT
Jiangsu GDK
KM Biologics
List of Tables
 Table 1. Global Paediatric Influenza Prevention Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Paediatric Influenza Prevention Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Paediatric Influenza Prevention Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Paediatric Influenza Prevention Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Paediatric Influenza Prevention Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Paediatric Influenza Prevention Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Paediatric Influenza Prevention Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Paediatric Influenza Prevention Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Paediatric Influenza Prevention, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Paediatric Influenza Prevention, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Paediatric Influenza Prevention, Product Type & Application
 Table 12. Global Key Manufacturers of Paediatric Influenza Prevention, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Paediatric Influenza Prevention by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Influenza Prevention as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Paediatric Influenza Prevention Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Paediatric Influenza Prevention Sales by Region (2019-2024) & (K Units)
 Table 18. Global Paediatric Influenza Prevention Sales Market Share by Region (2019-2024)
 Table 19. Global Paediatric Influenza Prevention Sales by Region (2025-2030) & (K Units)
 Table 20. Global Paediatric Influenza Prevention Sales Market Share by Region (2025-2030)
 Table 21. Global Paediatric Influenza Prevention Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Paediatric Influenza Prevention Revenue Market Share by Region (2019-2024)
 Table 23. Global Paediatric Influenza Prevention Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Paediatric Influenza Prevention Revenue Market Share by Region (2025-2030)
 Table 25. North America Paediatric Influenza Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Paediatric Influenza Prevention Sales by Country (2019-2024) & (K Units)
 Table 27. North America Paediatric Influenza Prevention Sales by Country (2025-2030) & (K Units)
 Table 28. North America Paediatric Influenza Prevention Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Paediatric Influenza Prevention Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Paediatric Influenza Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Paediatric Influenza Prevention Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Paediatric Influenza Prevention Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Paediatric Influenza Prevention Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Paediatric Influenza Prevention Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Paediatric Influenza Prevention Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Paediatric Influenza Prevention Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Paediatric Influenza Prevention Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Paediatric Influenza Prevention Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Paediatric Influenza Prevention Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Paediatric Influenza Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Paediatric Influenza Prevention Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Paediatric Influenza Prevention Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Paediatric Influenza Prevention Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Paediatric Influenza Prevention Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Paediatric Influenza Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Paediatric Influenza Prevention Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Paediatric Influenza Prevention Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Paediatric Influenza Prevention Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Paediatric Influenza Prevention Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Paediatric Influenza Prevention Sales (K Units) by Type (2019-2024)
 Table 51. Global Paediatric Influenza Prevention Sales (K Units) by Type (2025-2030)
 Table 52. Global Paediatric Influenza Prevention Sales Market Share by Type (2019-2024)
 Table 53. Global Paediatric Influenza Prevention Sales Market Share by Type (2025-2030)
 Table 54. Global Paediatric Influenza Prevention Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Paediatric Influenza Prevention Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Paediatric Influenza Prevention Revenue Market Share by Type (2019-2024)
 Table 57. Global Paediatric Influenza Prevention Revenue Market Share by Type (2025-2030)
 Table 58. Global Paediatric Influenza Prevention Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Paediatric Influenza Prevention Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Paediatric Influenza Prevention Sales (K Units) by Application (2019-2024)
 Table 61. Global Paediatric Influenza Prevention Sales (K Units) by Application (2025-2030)
 Table 62. Global Paediatric Influenza Prevention Sales Market Share by Application (2019-2024)
 Table 63. Global Paediatric Influenza Prevention Sales Market Share by Application (2025-2030)
 Table 64. Global Paediatric Influenza Prevention Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Paediatric Influenza Prevention Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Paediatric Influenza Prevention Revenue Market Share by Application (2019-2024)
 Table 67. Global Paediatric Influenza Prevention Revenue Market Share by Application (2025-2030)
 Table 68. Global Paediatric Influenza Prevention Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Paediatric Influenza Prevention Price (US$/Unit) by Application (2025-2030)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi Paediatric Influenza Prevention Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. CSL Paediatric Influenza Prevention Product
 Table 79. CSL Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. GSK Paediatric Influenza Prevention Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Viatris Paediatric Influenza Prevention Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. Hulan Bio Company Information
 Table 91. Hulan Bio Description and Business Overview
 Table 92. Hulan Bio Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Hulan Bio Paediatric Influenza Prevention Product
 Table 94. Hulan Bio Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. AstraZeneca Paediatric Influenza Prevention Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. CCBIO Company Information
 Table 101. CCBIO Description and Business Overview
 Table 102. CCBIO Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. CCBIO Paediatric Influenza Prevention Product
 Table 104. CCBIO Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Sinovac Paediatric Influenza Prevention Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. BCHT Company Information
 Table 111. BCHT Description and Business Overview
 Table 112. BCHT Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. BCHT Paediatric Influenza Prevention Product
 Table 114. BCHT Recent Developments/Updates
 Table 115. Jiangsu GDK Company Information
 Table 116. Jiangsu GDK Description and Business Overview
 Table 117. Jiangsu GDK Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Jiangsu GDK Paediatric Influenza Prevention Product
 Table 119. Jiangsu GDK Recent Developments/Updates
 Table 120. KM Biologics Company Information
 Table 121. KM Biologics Description and Business Overview
 Table 122. KM Biologics Paediatric Influenza Prevention Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. KM Biologics Paediatric Influenza Prevention Product
 Table 124. KM Biologics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Paediatric Influenza Prevention Distributors List
 Table 128. Paediatric Influenza Prevention Customers List
 Table 129. Paediatric Influenza Prevention Market Trends
 Table 130. Paediatric Influenza Prevention Market Drivers
 Table 131. Paediatric Influenza Prevention Market Challenges
 Table 132. Paediatric Influenza Prevention Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Paediatric Influenza Prevention
 Figure 2. Global Paediatric Influenza Prevention Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Paediatric Influenza Prevention Market Share by Type: 2023 & 2030
 Figure 4. Nasal Spray Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Paediatric Influenza Prevention Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Paediatric Influenza Prevention Market Share by Application: 2023 & 2030
 Figure 8. Public
 Figure 9. Private
 Figure 10. Global Paediatric Influenza Prevention Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Paediatric Influenza Prevention Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Paediatric Influenza Prevention Sales (2019-2030) & (K Units)
 Figure 13. Global Paediatric Influenza Prevention Average Price (US$/Unit) & (2019-2030)
 Figure 14. Paediatric Influenza Prevention Report Years Considered
 Figure 15. Paediatric Influenza Prevention Sales Share by Manufacturers in 2023
 Figure 16. Global Paediatric Influenza Prevention Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Paediatric Influenza Prevention Players: Market Share by Revenue in Paediatric Influenza Prevention in 2023
 Figure 18. Paediatric Influenza Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Paediatric Influenza Prevention Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Paediatric Influenza Prevention Sales Market Share by Country (2019-2030)
 Figure 21. North America Paediatric Influenza Prevention Revenue Market Share by Country (2019-2030)
 Figure 22. United States Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Paediatric Influenza Prevention Sales Market Share by Country (2019-2030)
 Figure 25. Europe Paediatric Influenza Prevention Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Paediatric Influenza Prevention Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Paediatric Influenza Prevention Revenue Market Share by Region (2019-2030)
 Figure 33. China Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Indonesia Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Thailand Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Malaysia Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Paediatric Influenza Prevention Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Paediatric Influenza Prevention Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Paediatric Influenza Prevention Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Paediatric Influenza Prevention Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Paediatric Influenza Prevention by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Paediatric Influenza Prevention by Type (2019-2030)
 Figure 53. Global Paediatric Influenza Prevention Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Paediatric Influenza Prevention by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Paediatric Influenza Prevention by Application (2019-2030)
 Figure 56. Global Paediatric Influenza Prevention Price (US$/Unit) by Application (2019-2030)
 Figure 57. Paediatric Influenza Prevention Value Chain
 Figure 58. Paediatric Influenza Prevention Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Flu Prevention Market Research Report 2024
Global Paediatric Influenza Treatment Market Research Report 2024
Global Pediatric Influenza Treatment Market Insights Forecast to 2030
Children Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Preventable Vaccine Market Research Report 2024
Global Flu Vaccination Market Research Report 2025
Global Human Injection Flu Vaccine Market Research Report 2025
Global Injection Influenza Vaccine Market Research Report 2025
Global Flu Vaccine Market Insights Forecast to 2030
Global Injection Flu Shot Market Research Report 2025
Global Vaccines For Children Market Insights Forecast to 2030
Global Influenza Subunit Vaccine Market Research Report 2024
Global Flu RNA Vaccines Market Research Report 2025
Global Pediatric Anti Flu Drugs Market Insights Forecast to 2030
Global Pediatric Healthcare Service Market Research Report 2024
Global Pediatric Healthcare Market Research Report 2025
Global Pediatric Anti Infective Drugs Market Research Report 2025
Global Combination Vaccines for Children Market Research Report 2024
Global Adult and Pediatric Vaccines Market Research Report 2024
Global Paediatric Mask Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions